PTPN11 and neoplasm: SHP099 stabilizes SHP2 in an autoinhibited conformation and blocks oncogenic activation of SHP2-RAS–ERK signaling, thereby inhibiting cancer cell proliferation and tumor propagation in xenograft models9.